TNF and Parkinson disease: However, treatment with anti-tumor necrosis factor therapies (anti-TNF) was demonstrated to substantially mitigate the incidence of PD by reducing systemic inflammation, which drives the tandem pathogenesis of IBD and PD, demonstrating a causal link of the gut–brain axis [22].